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Background:The proteins pentraxin 3 (PTX3) andTNF-stimulated gene-6 (TSG-6) and the proteoglycan inter--inhibitor
(II) are known to be involved in the stabilization of hyaluronan (HA)-rich extracellular matrices.
Results: PTX3 incorporation into HA matrices is tightly regulated.
Conclusion: PTX3, TSG-6, and II are sufficient to cross-link HA matrices.
Significance: The results provide mechanistic insights into the regulation of HA-protein interactions.
Mammalian oocytes are surrounded by a highly hydrated hya-
luronan (HA)-rich extracellularmatrixwith embedded cumulus
cells, forming the cumulus celloocyte complex (COC) matrix.
The correct assembly, stability, and mechanical properties of
thismatrix, which are crucial for successful ovulation, transport
of the COC to the oviduct, and its fertilization, depend on the
interaction between HA and specific HA-organizing proteins.
Although the proteins inter--inhibitor (II), pentraxin 3
(PTX3), and TNF-stimulated gene-6 (TSG-6) have been identi-
fied as being critical for COC matrix formation, its supramo-
lecular organization and the molecular mechanism of COC
matrix stabilization remain unknown. Here we used films of
end-grafted HA as a model system to investigate the molecular
interactions involved in the formation and stabilization of HA
matrices containing TSG-6, II, and PTX3. We found that
PTX3 binds neither to HA alone nor to HA films containing
TSG-6. This long pentraxin also failed to bind to products of the
interaction between II, TSG-6, and HA, among which are the
covalent heavy chain (HC)HA and HCTSG-6 complexes,
despite the fact that both II and TSG-6 are ligands of PTX3.
Interestingly, prior encounter with II was required for effec-
tive incorporation of PTX3 into TSG-6-loaded HA films. More-
over, we demonstrated that this ternary proteinmixturemade
of II, PTX3, and TSG-6 is sufficient to promote formation of
a stable (i.e. cross-linked) yet highly hydrated HAmatrix. We
propose that this mechanism is essential for correct assembly
of the COC matrix and may also have general implications in
other inflammatory processes that are associated with HA
cross-linking.
Manymammalian cells endow themselves with a pericellular
matrix, also named the cellular coat or glycocalyx, which is
located at the interface between the extracellular matrix and
the cellular membrane and typically defined by its direct
anchorage to the plasma membrane (1). Pericellular matrices
have been reported for a variety of cells in vivo and in vitro,
including fibroblasts (2, 3), chondrocytes (1, 4), epithelial cells
(5), cancer cells (6), monocytes (7, 8), and endothelial cells (9,
10). The mechanisms of pericellular matrix cross-linking as
well as how cross-linking alters the physico-chemical proper-
ties of the matrix and its functional activity remain poorly
understood. An illustrative example of a cross-linked hyaluro-
nan (HA)5 matrix is the cumulus celloocyte complex (COC)
matrix. This extended visco-elastic matrix grows around the
oocyte and cumulus cells a few hours before ovulation. The
COC matrix remains around the oocyte not only in the course
of ovulation but also during transport to the oviduct and is
required for successful fertilization in vivo (11, 12). COCexpan-
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sion is supported by the synthesis ofHA (13, 14), and it has been
suggested that HA in the matrix is organized in a hydrated
meshwork via the cross-linking of the HA chains (15). Until
now, three proteins have been described as essential for correct
assembly of the COC matrix: inter--inhibitor (II (16, 17)),
the secreted product of tumor necrosis factor-stimulated
gene-6 (TSG-6 (18)), and pentraxin 3 (PTX3 (12, 19)). Cur-
rently, we have a limited understanding of how HA and these
proteins interact with one another to stabilize the COCmatrix.
Fig. 1A outlines the ternary and quaternary structure of the
three proteins.
TSG-6 is a multifunctional protein expressed under inflam-
matory conditions (15, 20) and by cumulus cells in the preovu-
latory follicle (20–25). It has numerous ligands, among which
are HA (26, 27), II (21, 28, 29), and PTX3 (12, 30). TSG-6 is
composed of two domains: the Link module with its HA-bind-
ing domain (31–34) and the CUB module (Protein Data Bank
entry 2WNO) (35). In some cases, the Link module has been
found to elicit biological responses similar to full-length TSG-6
(36–39). However, this is not the case for the interaction with
HA; the Link module alone binds to HA in a simple manner,
whereas the full-length protein binds to HA cooperatively, due
to HA-induced TSG-6 oligomerization, a process that leads to
cross-linking of HA (40).
II is a complex proteoglycan constitutively present in
serum; it consists of two heavy chain subunits (HC1 and HC2)
covalently linked via a chondroitin sulfate glycosaminoglycan
to a light chain, bikunin (41–44). The interaction between II,
TSG-6, and HA is known to result in the formation of covalent
complexes (HAHCs, TSG-6HC) (21, 42, 43) and numerous
non-covalent complexes. In the presence of II, the HA-bind-
ing and the cross-linking properties of TSG-6 are impaired (45).
Instead, TSG-6 acts as a catalyst for the covalent transfer ofHCs
from the chondroitin sulfate chain of II onto HA (21). In the
COCmatrix, TSG-6 was found in two distinct populations: as a
TSG-6HC complex and in its native state (24, 25, 46). The
covalent modification of the HAmatrix with HCs is crucial for
COC matrix assembly; genetic deficiency of either bikunin
(which prevents assembly of intact II) or TSG-6 results in
matrix instability and female infertility (17, 18, 47). However,
the functional interplay betweenTSG-6 and II is not sufficient
to stabilize the COCmatrix becausemice deficient in PTX3 are
also unable to form stable cumulusmatrix and are severely sub-
fertile (48).
The soluble pattern recognition receptor PTX3, also called
TSG-14, is a member of the pentraxin family (49, 50). The pro-
tein assembles into amultimeric complex of eight identical sub-
units stabilized by disulfide bonds (51, 52). Each protomer com-
prises a C-terminal pentraxin domain, sharing homology with
the classical short pentraxins C-reactive protein and serum
amyloid P component and a uniqueN-terminal region. PTX3 is
an extracellular matrix protein that is expressed by a number of
both somatic and immune cell types, including cumulus cells, in
response to primary inflammatory stimuli and Toll-like recep-
tor agonists (53–56). PTX3 fulfills important functions in fer-
tility, vascular biology, and innate immunity (50, 57, 58). Its
diverse functionality can be related to its complex structure.
The PTX3 octamer has an elongated and asymmetric shape
(52). It is composed of two differently sized globular lobes con-
nected by a short stalk; the N- and C-terminal regions of PTX3
mediate binding to multiple ligands. Cumulus cells from
Ptx3/ mice are unable to organize into a functional matrix,
although the covalent modification of HA with HCs (HAHC)
remains unperturbed (12). The exogenous addition of PTX3
rescues COCmatrix formation ex vivo (12, 30). Although PTX3
does not interact with HA, it has been suggested that its incor-
poration can bemediated by TSG-6 via its Linkmodule domain
through two distinct binding sites forHA and PTX3 (12). Coor-
dinated expression of PTX3 and TSG-6 has been described in
leukocytes and endothelial cells under inflammatory condi-
tions (59) as well as in ovulation (12), suggesting that these
proteinsmay co-localize in certain tissues (60) and cooperate in
vivo.
More recently, in co-immunoprecipitation experiments on
matrix extracts from murine COCs, PTX3 was shown to asso-
ciate with HCs but not with the bikunin chain of II (48). Solid
phase binding assays indicated that there is a direct interaction
between the N-terminal domain of PTX3 and HCs. Moreover,
recombinant constructs of this domain recapitulate the func-
tional activity of PTX3 in ovulation (30, 48).
The oligomeric state of PTX3 is known to be functionally
important; mutants of both the intact protein and its N-termi-
nal region that form dimers were unable to rescue matrix
assembly in Ptx3/ COCs, whereas mutants that form tetra-
mers support formation of stable HA matrices (30, 51). PTX3
has been suggested to act as a HA cross-linker, which stabilizes
the COC matrix (12, 21, 48). It was proposed that direct inter-
action of PTX3 with TSG-6 or HCs (or both) is critical for
proper COC matrix assembly (48).
Despite the numerous data described above, a complete
mechanistic picture of COCmatrix formation and stabilization
remains elusive. It has been our long term goal to be able to
reconstitute the main features of this matrix in vitro based on a
minimal set of molecular building blocks (i.e. to thereby dem-
onstrate an understanding of this process).Here, we use films of
surface-grafted HA and a range of surface-sensitive techniques
to study in a well defined in vitro setting how II, PTX3, and
TSG-6 affect the composition and cohesion of HA-rich matri-
ces. We provide new insights into how these proteins act in a
cooperative and coordinated fashion. We show that TSG-6 on
its own cannot mediate PTX3 incorporation into HA films; nor
can PTX3 be incorporated into HA films that have been previ-
ously exposed to II and TSG-6. Our data indicate that prior
encounter of PTX3 and II is an essential requirement for suc-
cessful incorporation of PTX3. The final quaternary complex
assembled from HA, PTX3, TSG-6, and II (or parts of it, such
as theHCs) can cross-linkHA in away that is different from the
cross-linking that occurs with TSG-6 alone, such that the HA
films remain strongly hydrated.
EXPERIMENTAL PROCEDURES
Protein and Hyaluronan Preparations—Wild type human
TSG-6 Link module (Link_TSG6, 10.9 kDa) was expressed in
Escherichia coli as described previously (61, 62). Biotinylated
Link_TSG6 (b-Link_TSG6; species A) was made as before (63).
Full-length recombinant human TSG-6 (rhTSG-6, 30.1 kDa)
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was expressed in Drosophila Schneider 2 cells and purified as
described previously (64). II was purified from human serum
as described (65) and confirmed to contain bikunin, HC1, and
HC2 chains by Edman degradation and by liquid chromatogra-
phy with tandemmass spectrometry (LC/MS/MS) of themajor
band cut out from an SDS-polyacrylamide gel (representing
95% of protein in the preparation). We assign a molecular
mass value of 180 kDa for II (28) for molarity calculations,
which is in good agreementwith a size of169 kDa determined
by size exclusion chromatography with multiangle laser light
scattering.6 Recombinant human PTX3 8-mer (PTX; 344  7
kDa) was purified from a Chinese hamster ovary 3.5 cell line as
described previously (57). A dimer-forming mutant of the
PTX3 N-terminal domain (i.e. residues 18–170 of the prepro-
tein; N_PTX3_MUT) was obtained by replacing cysteines at
positions 47, 49, and 103 with serines as reported (39). Biotiny-
lated PTX3 was obtained by modification of the recombinant
protein with EZ-Link NHS-PEG4-Biotin (Thermo Scientific)
according to the manufacturer’s instructions; on average, 2
mol of biotin/mol of PTX3 protomer were incorporated, as
quantified with the HABA-biotin quantitation kit (Thermo
Scientific) used according to the manufacturer’s instruc-
tions. Rat anti-human PTX3 monoclonal antibody (MNB4)
was made as described previously (51, 66). Stock solutions of
all proteins were aliquoted and stored at 20 °C. Protein
solutions were thawed shortly before use and diluted to the
desired concentrations.
Lyophilized HA, biotinylated at its reducing end and with
well defined molecular masses of 1083  53 kDa or 837  54
kDa (i.e. two different batches of Select-HA B1000), was pur-
chased fromHyalose (Oklahoma City, OK). For reconstitution,
HA was taken up in ultrapure water at a stock concentration of
1 mg/ml, gently shaken overnight, aliquoted, and stored at
20 °C. Films of end-grafted HA on protein-repellent surfaces
were assembled as described previously (28, 40, 45). For the
solution-phase heavy chain transfer assays, HA decasaccharide
(Hyalose) was biotinylated at the reducing end (b-HA10) by
oxime ligation.7
A HEPES buffer (150 mMNaCl, 10 mMHEPES, pH 7.4, 2 mM
CaCl2, 5mMMgCl2, in ultrapurewater) was used throughout all
measurements. Protein and HA solutions at their final concen-
trations were prepared in this buffer.
Quartz Crystal Microbalance with Dissipation Monitoring—
QCM-D measurements were performed as described in detail
elsewhere (67, 68). The QCM-D response is sensitive to the
mass (including coupled water) and the viscoelastic properties
of the surface adlayer. Measurements were performed with a
Q-Sense E4 system (Biolin Scientific, Västra Frölunda, Sweden)
in flowmode (69) with flow speeds of typically 20l/min and at
a working temperature of 23 °C. QCM-D data were collected at
six overtones (n 3, 5, 7, 9, 11, and 13, corresponding to reso-
nance frequencies of15, 25, 35, 45, 55, and 65MHz). Changes
in dissipation and normalized frequency,ffn/n, of the fifth
overtone (n 5) are presented unless otherwise stated.Adsorp-
tion and interfacial processes on gold-coated QCM-D sensors
(QSX301, Biolin Scientific) weremonitored in situwith subsec-
ond time resolution (70).
For sufficiently rigid monolayers of proteins, the film thick-
ness can be estimated towithin an error of typically20%, from
dC/	 f, where  1.0 g/cm3 is the density of the bulk
solution and C 18.06 ng/cm2/Hz is the mass sensitivity con-
stant for a sensor with a fundamental resonance frequency of
4.95 MHz (71). For submonolayers of globular proteins, this
calculus provides an effective thickness that is smaller than the
extension of the protein perpendicular to the surface.
Spectroscopic Ellipsometry (SE)—SEmeasures changes in the
polarization of light upon reflection at a planar surface. We
employed SE (M2000V;Woollam, Lincoln, NE) in situ to quan-
tify adsorbed biomolecular masses in a time-resolved manner,
as described in detail elsewhere (40, 45, 69). Gold-coated silicon
wafers were used as substrates and installed in a custom-built
open cuvette with continuously stirred sample solution (150
l).
Solution-phase Heavy Chain Transfer Assays—Heavy chain
transfer assays with catalytic amounts of TSG-6 were carried
out as described by Rugg et al. (28). Briefly, 1.8 M II was
incubated with 0.27 M TSG-6 with excess b-HA10 (20 M) in
the presence or absence of 1.8 M PTX3 at 37 °C in HEPES-
buffered saline with 5 mMMgCl2. Reactions were halted at 0, 1,
2, and 4 h by the addition of SDS-sample loading buffer and
boiling for 3min. Samples were run on a 10%Tris-Tricine SDS-
polyacrylamide gel and transferred to a nitrocellulose mem-
brane. In contrast to the previously reported assay (28), we used
HA oligosaccharides in biotinylated form as a substrate for HC
transfer. This modification enabled highly specific detection of
the b-HA10HC product (and thus monitoring of HC transfer)
by fluorescently labeled streptavidin. Specifically, fluorescence
of streptavidin-conjugated Alexa 488 (Invitrogen) was visual-
ized using a ChemiDoc Imager (Bio-Rad), and band intensities
were quantified using ImageJ software.
WesternBlotting—Samplesof150-l volumewere extracted
from the ellipsometry cuvette and stored frozen in aliquots of
30l until required. The collectedmaterial was analyzed for the
presence of TSG-6, II and the subunits of II byWestern blot
(samples were electrophoresed on 4–12% NuPAGE BisTris
gels with SeeBlue Plus2 prestained standard (Invitrogen)),
using RAH-1 and anti-II (DAKO) antibodies, respectively,
with a LI-COR Odyssey system as described previously (45).
The presence of PTX3 in the eluates was assessed by Western
blot with chemiluminescence detection. Briefly, proteins in the
eluates were recovered using 15l of StrataClean resin (Agilent
Technologies) and incubated for 15 min at room temperature
under agitation, followed by a water wash. The resin-bound
material was denatured and reduced by heating at 70 °C for 10
min in sample loading buffer containing DTT (Invitrogen).
Proteins were separated by SDS-PAGE on 10% BisTris gels
(Invitrogen), using MOPS SDS running buffer, and transferred
onto 0.45-m PVDF membranes. PTX3 was detected with the
MNB4 rat monoclonal antibody (500 ng/ml), followed by a sec-
ondary anti-rat IgG HRP conjugate (1:5000 dilution; GE
Healthcare). Chemiluminescence was recorded on a Chemidoc
6 D. C. Briggs, J. J. Enghild, and A. J. Day, unpublished data.
7 D. Thakar, E. Migliorini, L. Coche-Guerente, R. Sadir, H. Lortat-Jacob, D. Botu-
ryn, O. Renaudet, P.Labbé, and R. P. Richter, submitted for publication.
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system (Bio-Rad), following the addition of enhanced chemilu-
minescence substrate (Millipore).
Colloidal Probe Reflection Interference-Contrast Microscopy—
The thickness of surface-bound HA films (837 kDa) was deter-
mined by triple-wavelength colloidal probe RICM, as described
previously (67, 72). Naked polystyrene microspheres of
25-m diameter (Polysciences, Eppelheim, Germany) or
SAv-functionalized polystyrene microspheres of 22.7-m
diameter (Spherotech, Lake Forest, IL) were used as colloidal
probes. HA films were assembled on gold-coated glass cover-
slips, using custom-built open cells with an internal volume of
50 l. Protein solutions at desired concentrations were added,
and the incubation time was set to 5 h. Colloidal probes were
added shortly before acquisition of RICM images.
Functionalization of Colloidal Beads with HA Films—
Streptavidin-functionalized polystyrene microspheres were
used. The stock solution at 0.5% (w/v) concentration was
washed by three cycles of adding a 5-fold volume excess of
ultrapure water, centrifugation at 5500 	 g for 10 min, and
removal of the supernatant. End-biotinylated HA (837 kDa)
was added to 0.5% (w/v) of particles at a final concentration of
50 g/ml (this would correspond to a bead surface area of 1
nm2/HA chain if all available chains were grafted to beads) in
HEPES buffer and incubated under agitation for 30min at room
temperature. UnboundHAwas eluted by five cycles ofwashing.
The HA-functionalized beads were used immediately after
preparation.
Quantification of theMobility of Colloidal Probes by RICM—
The motion of microspheres was monitored by RICM imaging
at a wavelength of 490 nm, at a rate of 8 frames/s and an expo-
sure time of 100 ms, for 62.5 s. From the images, variations in
the bead position were quantified in two perpendicular direc-
tions (x, y) parallel to the surface, with a resolution of the order
of 1 nm through custom-made image analysis software. From
the evolution of the spatial position as a function of time t, the
mean square displacement (MSD) was calculated. In some
assays, the microspheres were found to undergo a directed lat-
eral motion, in addition to random stochastic motion, presum-
ably driven by convection or by gravity on a slightly tilted sam-
ple, or by lateral drifts of the sample stage. To correct for the
directedmotion, we subtracted a linear fit from the x(t) and y(t)
data sets before computing the MSD. The statistical uncer-
tainty of the MSDs increases with lag time . We considered
only MSDs up to  0.625 s for further analysis. Based on the
number of data points per trace (500 frames), we estimate a
statistical uncertainty of18% for the MSDs at this lag time.
RESULTS
We employed purpose-designed solid-phase binding assays
to assess molecular and supramolecular interactions. Gold-
coated surfaces were functionalized with an oligoethylene gly-
col coating exposing biotin groups and a dense monolayer of
streptavidin (SAv), as described previously (40) (Fig. 1B). The
SAv layer displays sites for the stable immobilization of bioti-
nylated biomolecules and allows oriented immobilizationwhen
the biomolecules are site-specifically labeled (e.g. for HA). The
underlying oligoethylene glycol ensures that only biotinylated
species can bind directly to the surface (i.e. the binding is spe-
cific). QCM-D and SEwere used tomonitor the binding events.
Here, SE provided quantification of the adsorbed biomolecular
mass per unit surface area. TheQCM-D response is sensitive to
the amount of adsorbed ligand (including coupled solvent),
with a negative frequency shift f typically correlating with a
mass increase, and sensitive to mechanical properties as well as
morphological features of the biomolecular film, typically
reflected in the dissipation shift D (71).
PTX3 Interacts with Link_TSG6, rhTSG-6, and II in the
Absence of HA—PTX3 does not interact directly with HA (Fig.
1C). The incorporation of the protein intoHA-richmatrices (in
particular into the COC matrix) must hence be mediated by
other molecular players that interact with HA. TSG-6 (12) and
the HCs of II (48) have been proposed to be involved in this
process.
To confirm the functionality of our protein samples, we
probed the interaction of PTX3 with TSG-6 in the absence of
HA. The binding of wild type PTX3, which forms an octamer
(52) of approximately cuboid shape with a size of 9.6	 14.3	
26 nm3, and a mutant of its N-terminal domain whose oligo-
merization is restricted to dimers (N_PTX3_MUT) to biotiny-
lated Link_TSG6 (b-Link_TSG6) was first tested by QCM-D
(Fig. 1D). Clear responses in frequency (f) and dissipation
(D) upon incubation of the SAv-coated surface with b-Link_
TSG6 (Fig. 1D,middle and right) confirmed binding of the pro-
tein. No desorption was observed upon rinsing in buffer, and
Link_TSG6 lacking biotin did not bind (Fig. 1D, left), confirm-
ing that b-Link_TSG6 was firmly and specifically immobilized
through biotin. The addition of wild type PTX3 (Fig. 1D, mid-
dle) or N_PTX3_MUT (Fig. 1D, right) resulted in rapid and
pronounced binding. The interaction between Link_TSG6 and
PTX3 was specific (i.e. PTX3 did not bind to a Link_TSG6-free
surface; Fig. 1C) and rather stable (i.e. only a minor fraction of
the proteins desorbed within 10 min after rinsing in buffer).
N_PTX3_MUT bound with similar stability as the intact wild
type protein, consistent with the observation that it is the
N-terminal domain of PTX3 that mediates binding to TSG-6
(30, 60).
The dissipation shift for the protein films was sufficiently
small, such that effective film thicknesses can be estimated
from the frequency shifts (71) (i.e. as an additional element to
assess the quality of the proteins and their interaction). More
specifically, the interactions in this binding assay should gener-
ate (sub)monolayers of b-Link_TSG6 and the associated PTX3
constructs. For partial (or complete) monolayers of globular
proteins, the effective thickness should be smaller than (or
comparable with) the extension of the protein perpendicular to
the surface. The frequency shifts at the end of the incubation
processes correspond to effective film thicknesses of 2.5 and 1.4
nm for b-Link_TSG6 (Fig. 1D, middle and right, respectively;
the difference may reflect batch-to-batch variations in the
biotinylation of b-Link_TSG6 leading to different surface cov-
erages), 10 nm for PTX3/b-Link_TSG6 (Fig. 1D, middle), and
8 nm for N_PTX3_MUT/b-Link_TSG6 (Fig. 1D, right). These
values are indeed smaller than or comparable with the protein
dimensions (32, 40, 52) consistent with the formation of
(sub)monolayers.
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A reverse approach was used in a complementary SE assay,
such that biotinylated PTX3 (b-PTX3) was first immobilized at
a monomer surface density of 4.8 pmol/cm2, corresponding to
1 PTX3 octamer/280 nm2 (Fig. 1E). Here, binding of both
Link_TSG6 and rhTSG-6 (which is not available in a biotiny-
lated form) could be tested. In contrast to QCM-D, SE can
provide quantitative information about surface coverage and
binding stoichiometry. The addition of both TSG-6 constructs
at identical molar bulk concentrations yielded comparable
molar surface densities corresponding to 50% of the PTX3
monomer surface density. Assuming that the TSG-6 constructs
bind as monomers to the individual binding sites on PTX3 and
based on our previous observations (30, 58), this suggests that
each PTX3 octamer has four TSG-6 binding sites. However, we
cannot exclude the possibility that some binding sites are inac-
cessible due to steric constraints imposed by the surface and the
dense arrangement of proteins. Most of the bound protein
could not be eluted by rinsing in buffer, indicating that binding
is of high affinity, consistent with the QCM-D data (Fig. 1D).
Although Link_TSG6 and rhTSG-6 bound in similar amounts
and with similar stability, they differ in their adsorption kinet-
ics; Link_TSG6 bound rapidly with an initial binding rate that
FIGURE 1. A, proteins involved in HA matrix stabilization. Ternary and quaternary structures are schematically shown, with the sizes of all proteins and their
subunits approximately to scale and known interactions indicated by arrows. Subunits that were used separately in addition to the complete protein are
enclosed within dashed boxes. B, schematic illustration of the platform for solid-phase binding assays. A gold support was modified with a protein-repellent
oligoethylene glycol monolayer functionalized with biotin, followed by the formation of a densemonolayer of well oriented SAv. HA, Link_TSG6, or PTX3 was
grafted to the SAv layer via biotin tags. HA chains were site-specifically functionalizedwith biotin at their reducing end and could therefore be immobilized at
controlled orientation. Proteins were functionalized through primary amines and thereforemight be immobilized in a variety of orientations. The thickness of
the oligoethylene glycol monolayer and the dimensions of SAv, Link_TSG6, and the PTX3 octamer are drawn approximately to scale; the thickness of the HA
brush and the mean distance between HA anchor points are reduced by 10–20-fold for illustrative purposes. C, interaction of PTX3, II, and a mixture of
II/PTX3 with HA film. A control shows that 1 M II, 0.3 M PTX3, and a mixture of these proteins do not bind to HA in the absence of TSG-6. The start and
duration of the incubationwith different samples are indicated (arrows). After each incubation step, the solution phasewas replaced by buffer. QCM-Ddid not
showany significant interactionbetween theHA film (58 kDa) and II, PTX3, or a PTX3/IImixture. The employedHA films are easily permeatedby theproteins
(cf. Fig. 4B). The controlmeasurements therefore also confirm that our streptavidin-coated surfaces are resistant to nonspecific binding of II or PTX3, alone or
in a mixture. D, interaction of surface-bound Link_TSG6 with octamer-forming wild type PTX3 and dimer-forming N_PTX3_MUT. Interactions were measured
by QCM-D. Biotinylated Link_TSG6 (b-Link_TSG6) but not Link_TSG6 without biotin was immobilized to a streptavidin monolayer, and binding of PTX3
constructs was monitored. The bulk PTX3 concentration refers to the molar concentration of PTX3 monomers. E, interaction of surface-bound PTX3 with
Link_TSG6 and rhTSG-6. Interactions were measured by SE. b-PTX3 was immobilized, and binding of Link_TSG6 and rhTSG-6 was monitored. F, interaction of
surface-bound PTX3with II. Interactions weremeasured by QCM-D. b-PTX3was immobilized, and binding of II wasmonitored. The curves shown in C–F are
representative of sets of measurements performed at least in duplicate.
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suggests mass transport-limited binding, whereas rhTSG-6
bound much more slowly. The distinctly different binding
kinetics might well reflect differences in themode of binding of
these TSG-6 constructs, such as previously reported for their
binding to HA (40). However, we cannot fully exclude the pos-
sibility that the decreased binding rate for rhTSG-6 is due to
steric effects; the solid support and crowding might partially
mask TSG-6 binding sites in the PTX3 monolayer, rendering
binding of rhTSG-6 (30 kDa) more difficult than that of the
smaller Link_TSG6 (11 kDa). Taken together, these data pro-
vide clear evidence for a strong interaction between TSG-6 and
PTX3. The results are consistent with a binding mediated
through the Linkmodule of TSG-6 to a dimer of theN-terminal
region of PTX3, as has been concluded previously (30, 60).
An additional QCM-D assay with surfaces exposing amono-
layer of b-PTX3 (Fig. 1F) confirmed that II binds to PTX3, as
expected (30). As observed for TSG-6, binding was rather sta-
ble, with only a minor fraction of the proteins being desorbed
within 10 min after rinsing in buffer.
Ternary Interaction between TSG-6 Constructs, PTX3, and
HA—The ternary interaction between HA, PTX3, and TSG-6
could lead to incorporation of PTX3 into HA matrices only if
the HA and PTX3 binding sites on TSG-6 do not interfere with
each other. To test whether this is the case, we performed a
sequential binding assay (Fig. 2). First, the HA film was incu-
batedwith Link_TSG6 at a bulk concentration of 5M (Fig. 2A).
The surface density of adsorbed material at equilibrium was
215  16 ng/cm2, corresponding to an occupancy of 1 Link_
TSG6/1 HA decasaccharide, in good agreement with previous
work (40). An excess of Link_TSG6 was maintained in the bulk
solution, and no rinsing step was included, to prevent desorp-
tion of Link_TSG6, which would otherwise occur rapidly (40).
The addition of PTX3 at a bulk monomer concentration of
0.3 M resulted in a large increase in the adsorbed mass. The
surface density of incorporated material was 418 55 ng/cm2.
Because PTX3 alone does not interact with HA (Fig. 1C), we
conclude that its incorporation is Link_TSG6-mediated, as
proposed before (12, 21). Hence, the binding sites for HA and
PTX3 on Link_TSG6 do not overlap, allowing Link_TSG6 to
act as a linker for PTX3 incorporation into HA matrices.
Surprisingly, PTX3 did not show any measurable binding if
the HA film was preloaded with full-length TSG-6 instead of
Link_TSG6. Consistent with this, subsequent incubation with
the MNB4 antibody, which recognizes the N-terminal domain
of PTX3, did not lead to any increase in binding signal (i.e. it did
not appreciably affect the rhTSG-6 unbinding curve) (Fig. 2B).
However, from Fig. 1, D and E, as well as previous reports (12,
30, 60), we know that rhTSG6 can interact with PTX3 in the
absence of HA. Thus, it would appear that the interaction of
rhTSG-6 with PTX3 is perturbed by HA. To shed light on this,
we performed binding assays in which theHA filmwas exposed
to a constant amount of PTX3, along with increasing concen-
trations of either Link_TSG6 (Fig. 3A) or rhTSG-6 (Fig. 3B). For
comparison, both TSG-6 constructs were also titrated into the
HA film in the absence of PTX3 and were found to exhibit
distinct binding (Fig. 3), as has beennoted previously (40); bind-
ing of rhTSG-6 toHA is characterized by a pronounced positive
cooperativity, and the K0.5 is about 5-fold lower than for
Link_TSG6.
However, the amount of adsorbed Link_TSG6was greater in
the presence of PTX3 (Fig. 3A), consistent with the first binding
assay (Fig. 2A). It is notable that enhanced binding was
observed when Link_TSG6 was present in solution at 2 M
but not with lower Link_TSG6 concentrations. Moreover, the
binding isotherm in the presence of PTX3 (Fig. 3A, filled circles)
exhibited a pronounced sigmoidal shape, where a fit with the
Hill equation gave an exponent of 3.6, indicative of cooperativ-
ity, withK0.5 2.9M and 
max 945 ng/cm2. In contrast, a fit
to the data from Link_TSG6 alone gave an exponent of 1.3 (i.e.
close to 1.0) and K0.5  4.6 M, which is in agreement with
previous reports (40) and is indicative of simple non-coopera-
tive binding. Thus, the cooperative binding behavior in the
presence of PTX3 must somehow originate from the interac-
tion of Link_TSG6 with PTX3. More specifically, binding of
Link_TSG6 to PTX3 or, alternatively, of the Link_TSG6PTX3
complex to HA must be cooperative.
Removal of proteins from the bulk solution after the titration
assays (not shown) revealed distinct rates of protein dissocia-
tion from the HA film. The dissociation rate of Link_TSG6
alone (31  2 	 103 s1; not shown) was comparable with
FIGURE 2. PTX3 does not incorporate into HA films via full-length rhTSG-6, but it does via Link_TSG6. The HA film (837 kDa) was first loaded with
Link_TSG6 (A) and rhTSG-6 (B). After equilibriumwas established, free TSG-6 protein remained in solution. The addition of PTX3 revealed fast adsorption to the
Link_TSG6-loaded HA film but not to the rhTSG-6-loaded HA film. The gray solid line in B is a linear fit revealing an initial binding rate of 44 ng/cm2/min. The
addition of 0.08 M anti-PTX3 antibody (MNB4) in the rinsing phase in B did not affect the unbinding curve. The SE curves shown are representative of sets of
measurements performed at least in duplicate.
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previously reported rates on polymeric HA and oligo-HA films
(40). The dissociation rate in the presence of PTX3 (14.7 
0.6 	 103 s1) was 2 times lower than for Link_TSG6 alone.
The decrease in desorption rate might indicate that the
PTX3Link_TSG6 complex binds to the films in a multivalent
manner or that PTX3 enhances the HA binding activity of
Link_TSG6.
Within the experimentally accessible range of rhTSG-6 con-
centrations (up to 2M), PTX3 inhibited protein binding toHA
in a dose-dependent manner. The addition of a monoclonal
anti-PTX3 antibody (MNB4) to the protein-loaded HA films at
the end of the titrations did not result in any significant
response (not shown), confirming that the bound protein
material consisted exclusively of rhTSG-6. Apparently,
PTX3 competes with HA for the binding of rhTSG-6. As a
consequence, we conclude that PTX3 cannot be incorpo-
rated into HA matrices through rhTSG-6 alone, contrary to
what has been proposed in the literature (12) based on the
observation that Link_TSG6 can bind to PTX3 and HA.
Interaction of PTX3 with HA Films ThatWere Pre-exposed to
TSG-6 and II—PTX3 is also known to bind to intact II (30,
48), and it has been proposed that PTX3 incorporates into HA
matrices through interaction with HCs (48). The latter can be
covalently transferred from II to HA via a reaction that is
catalyzed by TSG-6 (21). To test this hypothesis, we first
exposedHA films to amixture of TSG-6 and II and then stud-
ied PTX3 binding (Fig. 4A).
Incubation with 0.3 M PTX3 and subsequently with anti-
PTX3 antibody (MNB4) revealed that the TSG-6/II-exposed
film did not bind significant amounts of PTX3. This unex-
pected finding seems to indicate that when II forms ternary
interactions with TSG-6 and HA, it is no longer able to bind
PTX3. Alternatively, one may argue that PTX3 binding is sim-
ply limited by the access of the protein to the interior of the HA
film. In this regard, PTX3 forms octamers in solution (52) that
are significantly larger than TSG-6 or II.
Thus, to test whether PTX3 is sterically excluded from HA
films, we performed permeation assays using b-PTX3 (Fig. 4B).
The assay exploits the fact that only a small fraction (1%) of
the biotin binding sites on the SAv monolayer that accommo-
dates the HA film are occupied by b-HA (67). Biotinylated
PTX3 that diffuses through the HA film should hence find
plenty of sites to bind through its biotinmoieties. b-PTX3 read-
ily bound to a plain SAv monolayer and to SAv monolayers
covered with HA films with a surface density of 35 5 ng/cm2
that were pure or had been incubated with 0.3 M rhTSG-6,
alone or in a mixture with 1 M II. Importantly, the initial
b-PTX3 binding rates for all of the HA films tested here did not
differ significantly from the initial rate on the plain SAv surface
(Fig. 4B), indicating that the different HA films do not signifi-
cantly affect the accessibility of b-PTX3 to SAv. Clearly, all of
these HA films retained good permeability to PTX3. Taken
together, we must conclude, based on the data presented in
Figs. 1C, 2B, 3B, and 4, that neither pure HA films nor HA films
treated with TSG-6 or with a mixture of TSG-6 and II present
appropriate PTX3 binding sites.
How to Incorporate PTX3 into HA Films?—The absence of
PTX3 binding in the above-described assays disproves existing
hypotheses about the mechanism by which PTX3 is incorpo-
rated into HA matrices (12, 48). On the other hand, PTX3 has
been shown to be an essential component in the formation of
the COC matrix (12). So how is PTX3 incorporated into HA
films? We hypothesized that PTX3 must encounter II and/or
TSG-6 prior to interaction with HA in order for PTX3 to be
incorporated into HA assemblies. To test this hypothesis, we
first added PTX3 and II at bulk concentrations of 0.3 and 1
M, respectively, to anHA film. As anticipated, thismixture did
not show anyHA binding activity (Fig. 1C) (45). Second, TSG-6
was added at a bulk concentration of 0.3 M. This protein did
start a binding reaction (Fig. 5A). After 2 h of incubation, all
proteins in the soluble phase were removed. Following this, the
anti-PTX3 antibody (MNB4) did bind to the film. In contrast,
the same antibody did not bind to an HA film that contained
TSG-6 (Fig. 2B). This provides strong evidence that co-incuba-
tion of PTX3 in a ternarymixturewith II andTSG-6 promotes
PTX3 incorporation into the HA film.
FIGURE 3.PTX3differentiallymodulates the interactions of Link_TSG6 and full length TSG-6withHA.A, PTX3modulates Link_TSG6 interactionwith HA.
Binding isotherms obtained from titration of Link_TSG-6 into an HA film, monitored by SE, in the presence or absence of 0.3M PTX3 in the solution phase. A
fit (solid line) of the titration data for Link_TSG6 (filled triangles) with the Hill equation gave a Hill exponent close to 1.0, confirming a simple non-cooperative
interaction between HA and Link_TSG6. In the presence of PTX3, the interaction is more complex. The sigmoidal shape of the data (filled circles) indicates
cooperative binding. A fit with the Hill equation (dashed line) indeed provides a Hill exponent of 3.6 (i.e.much larger than 1.0). B, competition of PTX3 and HA
for TSG-6 binding. Binding isotherms obtained from titration of rhTSG-6 into an HA film, alone (filled circles) and in the presence of 0.3 M (filled triangles) or 1
M (empty triangles) PTX3 in the solutionphase. At abulk rhTSG-6 concentrationof 0.45M, an3-folddecrease in the surfacedensity of adsorbed rhTSG-6 can
be detected in the presence of 0.3 M PTX3. At 1 M PTX3, the decrease in binding becomes even more pronounced.
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We carried out additional measurements (by QCM-D; Fig.
5B) to test whether the sequence of protein encounter is critical
for PTX3 incorporation. In one case, PTX3was firstmixedwith
TSG-6 and then with II before themixture was exposed to the
HA film. In a second measurement, TSG-6 and II were mixed
first, and then PTX3 was added before exposure to HA. In both
cases, PTX3 was incorporated into the HA films, as evidenced
by subsequent binding of anti-PTX3 antibody. We conclude
that the order of protein encounter is not critical for PTX3
incorporation.
It is difficult to quantify the amount of incorporated PTX3
based on bound antibody; accessibility to PTX3 in the HA film
might be limited, and it is also not clear if the antibody can bind
simultaneously to all monomers in the PTX3 octamer. How-
ever, by assuming a stoichiometry of one antibody per PTX3
monomer and using a molecular mass of the antibody of 150
kDa, a lower limit for the amount of incorporated PTX3 in Fig.
5A can be estimated as 0.6 pmol/cm2. For comparison, the den-
sity of TSG-6 when incubated alone at the same concentration
would be about 20-fold higher.
Our data do not provide a full picture of the exact composition
of the polysaccharide-protein assembly that forms upon interac-
tion of the ternary proteinmixture withHA. Considering that the
four starting molecules can engage in a variety of homotypic and
heterotypic interactions, it is also difficult to suggest which mole-
cule/molecular complex acts as the ligand for PTX3.However, we
canextract some informationabout the functional roleofPTX3by
analyzing the kinetics of the binding reaction and the stability of
binding from the ternary protein mixture.
The initial rate of the binding reaction in the presence of all
three proteins (Fig. 5A, straight gray line) wasmore than 5 times
smaller than the initial binding rates of TSG-6 alone (Fig. 2B,
straight gray line) and about 2 times smaller than the reaction
rate for the binary mixture of TSG-6 and II (Fig. 4A, straight
gray line). This indicates that the propensity of II to (partially)
impair the binding of TSG-6 toHA (45) is retained and perhaps
even enhanced in the presence of PTX3.
To test whether PTX3 influences the competition between
II and HA for TSG-6, we performed another sequential incu-
bation assay (Fig. 6A); here II and PTX3 were premixed and
FIGURE 4. PTX3 does not bind toHA films that had previously been exposed to amixture of II/TSG-6. A, binding assays by SE. 1M II and 0.3M TSG-6
were sequentially added to theHA filmwithout premixing. In this case, the film contains an additional fraction of non-covalently but stably boundprotein (45).
The gray solid line is a linear fit revealing an initial binding rate of 13 ng/cm2/min. Incubation with 0.3 M PTX3 does not affect the surface density of the film.
The lack of a significant response upon incubation with 0.08 M anti-PTX3 antibody (MNB4) confirms the absence of PTX3 binding. The curve shown is
representative of a set of measurements performed in duplicate. B, HA films are permeable to PTX3. b-PTX3 was added to SAv-covered surfaces without any
further functionalization (solid line) or in the presence of HA (837 kDa) filmswith a surface density of 35 5 ng/cm2. HA filmswere presented pure (dashed line)
or following exposure to 0.3M rhTSG-6 (solid linewith open circles) or to amixture of 1M II and 0.3M TSG-6 (premixed for 1min before the addition to the
HA film; solid line with filled squares). Only initial binding is shown. Binding with similar rates is observed for all surfaces. Because PTX3 alone did not show
binding on any of these surfaces, the binding of b-PTX3 must occur via the biotin moiety to SAv, indicating that all HA films are permeable to PTX3.
FIGURE5.PTX3 incorporates intoHAfilmswhenpresented ina ternarymixturewithTSG-6and II.A, bindingassaybySE.HA filmswere first exposed to0.3M
PTX3.After 2minof incubation, 1M IIwas added, andafter another 2.5min, 0.3M rhTSG-6was added. Bindingensuedafter the additionof rhTSG-6; thegray solid
line is a linear fit revealing an initial binding rate of 6 ng/cm2/min. The protein mixtures were incubated with the HA films for 2 h. Subsequent binding of anti-PTX3
antibody, incubated at 0.08 M, indicates successful incorporation of PTX3. The curve shown is representative of a set of measurements performed in duplicate. B,
bindingassaybyQCM-D.f (blue lines) andD (orange lines) are shown.MixturesofPTX3, rhTSG-6, and IIwereexposed toHA filmsat final protein concentrationsof
1.0,0.6, and0.2M, respectively. Inonecase (circles), PTX3was firstmixedwithTSG-6 for2handthenwith II foranother1h (all at roomtemperature)beforeexposure
toHA. In theother case (triangles), TSG-6 and IIweremixed first (for 2h), and thenPTX3was added (for 1h)before exposure toHA.ClearQCM-D responsesupon the
subsequent addition of anti-PTX3 antibody, incubated at 0.08M, indicated successful incorporation of PTX3.
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then exposed to aTSG-6-loadedHA film (where theTSG-6 had
been removed from the bulk solution and the HA-associated
protein was beginning to dissociate). Linear fits allowed us to
approximate the unbinding rates just before (3.7 ng/cm2/min;
green dashed line) and after the addition of II/PTX3 (27
ng/cm2/min; red dashed line). Comparison with the displace-
ment induced by II alone (Fig. 6B; reproduced from Ref. 45)
did not reveal any significant difference. Also, the fraction of
stably but non-covalently bound material that persisted after
incubation with II and PTX3 was comparable with the frac-
tion displaced by II alone (30 and 35%, respectively). Hence,
PTX3 does not affect the propensity of II to displace TSG-6
from HA. More generally, this finding would indicate that
PTX3 does not influence the initial interaction between TSG-6
and II.
Approximately 10 min after the start of incubation with II
and PTX3 (Fig. 6A, at 107 min), an increase in the surface den-
sity was observed.We had already seen a similar effect with II
alone (Fig. 6B) (45) and concluded that this response relates to
transfer of HCs onto HA, accompanied by the incorporation of
several non-covalently bound protein species into the HA film.
The overall similarity in the rates and magnitudes of binding
suggests that similar processes occur also in the presence of
PTX3, yet a detailed comparison of the binding curves reveals
distinct shapes; the curve for II alone (Fig. 6B) (45) was linear
overmore than 3 h of incubation, whereas the binding curve for
the mixture of II and PTX3 (Fig. 6A) is well approximated by
an exponential with a half-time of 90 min. Previously, we have
proposed that the linear response is a signature of the TSG-6-
mediated transfer of HCs from II onto HA (45), with TSG-6
acting as a catalyst (23). In this context, the exponentially
decaying binding rate in Fig. 6Amight indicate that, in the pres-
ence of PTX3, TSG-6 is consumed in the HC transfer reaction.
In other words, we propose that PTX3 inhibits recycling of
TSG-6.
To test this hypothesis, we performed complementary HC
transfer assays in solution, inwhich catalytic amounts of TSG-6
(28) were co-incubated with II and a biotinylated HA oligo-
saccharide (b-HA10) in the absence/presence of PTX3 (Fig. 7).
In the absence of PTX3, transfer rates remained virtually
unchanged throughout the total 4-h incubation time (based on
the visualization of b-HA10HC species; see Fig. 7A), consistent
with the linear response in Fig. 6B. In contrast, in the presence
of PTX3, transfer proceeded throughout the first hour but then
FIGURE 6. PTX3 in a mixture with II incorporates into TSG-6-loaded HA
films. A, the HA film was first loaded with 0.3 M TSG-6, excess protein was
removed from the solution phase, and amixture of 0.3M PTX3, 1M II was
added (premixed for 1 min). The addition of the PTX3/II mixture first
enhanced desorption until a mass fraction of 35% remained, and thereafter
incorporation of material into the HA film started. The addition of anti-PTX3,
after the removal of excess protein in the solution phase, confirmed PTX3
incorporation into the film.Only a small fractionof about 12%couldbeeluted
with 2 M GdnHCl, whereas most material was eluted with 8 M GdnHCl. A frac-
tion of 10% remained bound in 8 M GdnHCl but could be largely digested by
hyaluronidase. The increase in the desorption rate upon the addition of II/
PTX3 can be appreciated from the linear fits to the data shortly before (green
dashed line; 3.7 ng/cm2/min) and after (red dashed line; 27 ng/cm2/min) pro-
tein addition. The adsorption process setting in 10 min after incubation with
II/PTX3 was fitted by an exponential (gray dashed line). The fit revealed a
maximal surface density of 660 ng/cm2 and a half-time of about 90 min. The
curve shown is representative of a set of measurements performed in dupli-
cate. B, equivalentmeasurementwith II instead of amixture of II and PTX3,
with linear fits to the data shortly before (green dashed line; 2.9 ng/cm2/min)
and after (orange dashed line; 31 ng/cm2/min) II addition, reproduced from
Fig. 1B in Ref. 45. In this case, the adsorption process, commencing 10 min
after incubationwith II, could be fittedwith a straight line (gray dashed line).
FIGURE 7. PTX3 inhibits the catalytic activity of TSG-6 in HC transfer. In a
solution-phase assay, 0.27 M TSG-6, 1.8 M II, and 20 M b-HA10 were co-
incubated with or without 1.8 M PTX3 for various times and subsequently
analyzed by Western blots with streptavidin-conjugated Alexa 488, which
recognizes biotin in b-HA10HC complexes. A, Western blot with co-incuba-
tion times indicated. B, densitometric analysis ofWestern blots. Error bars, S.E.
from three blots. Data are representative of two independent experiments.
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essentially halted. These data provide independent confirma-
tion that PTX3 reduces the ability of TSG-6 to transfer heavy
chains and are fully consistent with our proposal that PTX3
inhibits recycling of TSG-6. It should be noted that the experi-
ments in Figs. 6 and 7were conducted at different temperatures
(24 and 37 °C, respectively) and that the rate of encounter
between HA and the proteins is higher with HA in the solution
phase, which probably explains the different time scales over
which this inhibition was observed.
Stability of PTX3 Incorporation and Effect of PTX3 on HA
Film Composition—To analyze the composition of the HA film
after protein incubation, we performed Western blot analyses
(with anti-PTX3, anti-TSG-6, and anti-II antibodies) of mate-
rial collected from the incubation assays in Figs. 4A and 5 after
exposure sequentially to 2 M GdnHCl, 8 M GdnHCl, and hyalu-
ronidase. The anti-PTX3 antibodyMNB4 (Fig. 8A) revealed the
two strongest bands to be in the 8 M GdnHCl eluate from the
ternary protein mixture; the apparent molecular masses of
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these bands (about 45 and 90 kDa) were identical to that of the
PTX3monomer and dimer that are present in a control sample.
No bands were found at these positions in the 2 M GdnHCl
eluates and the hyaluronidase digests (or the 8MGdnHCl eluate
from the II/TSG-6 binary mixture). This indicates that most,
if not all, PTX3 is very tightly yet non-covalently bound to the
HA matrix. Some immunoreactive bands were observed at 55
and 28 kDa in samples from 2 M GdnHCl washes (Fig. 8A,
labeled as a and b, respectively). Thesemight correspond to the
heavy and light chains, respectively, of antibody leftovers in the
measurement chamber from the injections performed in Figs.
4A and 5. Also a band at about 65 kDa (Fig. 8A, labeled as c) is
present, probably due to sample contamination with BSA, that
is nonspecifically recognized by the applied antibody.
The staining patterns with the anti-TSG-6 and anti-II anti-
bodies (Fig. 8, B and C) were consistent with our previous
reports (45) (i.e. rhTSG-6 protein andHCTSG-6were found in
all GdnHCl eluates but not in the hyaluronidase digest, whereas
HC was also found in the hyaluronidase digest). Notably, the
blots of eluates and digests retrieved from the PTX3-containing
HA films were very similar to the corresponding ones from the
PTX3-freeHA film. Apparently, the presence of PTX3 does not
appreciably affect the incorporation of TSG-6, the HCs of II,
or HCTSG-6 complexes into the HA film.
In theWestern blots in Fig. 8, B andC, we assign the bands at
apparent molecular masses of 170 and 34 kDa to II and
TSG-6, respectively; these bands were clearly the dominant
ones in control gels (using the same gel type and molecular
weight standards) with Coomassie Blue staining of the II and
TSG-6 preparations (Fig. 8D, right), demonstrating the purity
of the two protein preparations. However, when using molecu-
lar masses from Ref. 28 for the SeeBlue Plus2 standards in the
context of a 10% Tris/Tricine gel, an apparent molecular mass
of220 kDa is observed for the same II preparation (Fig. 8D,
left); similar values have been reported previously by us and
others (28, 73–75). Thus, it can be seen that the gel system used
and the masses assigned to standards have a large influence on
the apparent molecular weight determined for II from SDS-
PAGE; as noted above, the mass of II determined in solution
by a biophysical method is 169 kDa (see “Experimental
Procedures”).
Additional bands, located between 100 and 160 kDa, that are
hardly visible with Coomassie Blue staining are rather pro-
nounced within the II control in the Western blot developed
with the anti-II antibody (Fig. 8B). It seems likely that these
species represent minor traces of II degradation and that the
enhanced relative intensity in theWestern blot originates from
an overproportional sensitivity of the polyclonal anti-II anti-
body for the degraded species. Other faint bands are also
detectable slightly above the II band onCoomassie Blue stain-
ing (Fig. 8D, right), whichwe suggest represent II-like proteins
with three or four heavy chains attached to the bikunin-chon-
droitin sulfate proteoglycan; we have referred to these previ-
ously as high molecular weight II, which are low abundance
forms of II found in plasma (42) and which are also generated
as by-products during HCTSG-6 complex formation (see Fig.
8D) (29, 42, 45).
Structural Role of PTX3—PTX3 has been suggested to act as
anHA cross-linker that stabilizes the COCmatrix (12, 48). Fur-
thermore, the oligomeric state of PTX3 is known to be func-
tionally important: mutants of both PTX3 and its N-terminal
region that form dimers were unable to rescuematrix assembly
in Ptx3/ COCs; in contrast, the wild type octamer-forming
protein and tetramer-forming mutant constructs, made in the
context of both full-length PTX3 and its N-terminal domain,
did support formation of stable HA matrices (30).
To test whether PTX3 affects the morphology of HA mesh-
works, wemonitored the response ofHA films to incorporation
of different protein mixtures by QCM-D (Fig. 9A). The
response to a binary mixture of II and TSG-6 was compared
with that to ternary protein mixtures including either PTX3 or
N_PTX3_MUT (150–410min). The signals observed upon the
addition of the anti-PTX3 antibody (at 445 min) provide evi-
dence that not only wild type PTX3 but also N_PTX3_MUT
bind.
Parametric plots of D versus f are useful to detect changes
in the morphology or mechanical properties of surface-con-
fined films (76–78). The strong similarities in such plots (Fig.
9B) for films containing II and TSG-6 and films containing
additionally N_PTX3_MUT and the clear differences com-
pared with films containing intact PTX3 provide strong evi-
dence that PTX3, but not its dimeric N-terminal region, mod-
ifies the morphology and/or mechanical properties of the HA
film as compared with the binary protein mixture of II and
TSG-6. We stress that the qualitative analysis of D versus f
plots is appropriate for films of arbitrary morphological or
mechanical complexity. It is also robust because it makes use of
the raw data alone. In contrast, we did not attempt to obtain
quantitative insight into the nature of the changes occurring in
the presence of intact PTX3 from QCM-D data; because these
FIGURE 8. Western blot analysis of protein material incorporated into HA films. A–C, HA films were incubated with proteins in binary (II/TSG-6) and
ternary (II/TSG-6/PTX3) mixtures, as shown in Figs. 4A and 5, respectively. Western blots were made from fractions obtained by stepwise elution with 2 and
8 M GdnHCl and by digestion with hyaluronidase (HA-ase). Collectedmaterial was analyzed byWestern blots with anti-PTX3 (A), anti-II (B), and anti-TSG-6 (C)
antibodies. The control reactionmix of TSG-6, HA14, and II is expected to contain a total amount of 100 ng of TSG-6 and 25 ng of II, the control lane for PTX3
is expected to contain 500pgof PTX3, and thedetection limits are estimated tobearound5ng for TSG-6, 0.5 ng for II, and50pg for PTX3.D, direct comparison
of II and TSG-6 proteins running in 4–12% NuPAGE BisTris gels (used in B and C) and 10% Tris/Tricine gels (used by Rugg et al. (28)), stained with Coomassie
Blue. The same standards were used for both gel types (as indicated), and their apparent molecular masses were assigned following the manufacturer’s
indications for NuPAGE BisTris 4–12 with MES (as in B and C) and Tris-glycine gels (as in Ref. 28), respectively. II and TSG-6 were mixed (1.8 and 2.7 M,
respectively) and co-incubated at 4 °C using the standard conditions (as described in Ref. 28). Immediately aftermixing (0 h), bands for intact II and TSG-6 are
dominant; after 2 h of co-incubation, additional bands for HCbikunin/HCTSG-6 appear. In the 10% Tris/Tricine gel, II, HCbikunin, the HCTSG-6 doublet, and
TSG-6 run at apparentmolecularmasses of220,130,120, and38 kDa, respectively, consistentwith Rugg et al. (28), where these had been identified by
Edman degradation and mass spectrometry. In the 4–12% NuPAGE BisTris gels, the apparent molecular masses for II and TSG-6 are 170 and 34 kDa,
respectively; the HCbikunin and HCTSG-6 species run together with an apparent molecular mass of98 kDa. HMW II, a high molecular weight form of II
with three or four HCs attached, which is a minor species within the II preparation purified from serum that also forms as a by-product of HCTSG-6 complex
formation (see Ref. 29).
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HA films are generally very soft (as can be appreciated from the
large magnitude of the dissipation shifts or, more accurately,
the large D/f ratio (71)), this would require multiparam-
eter data fitting through viscoelastic modeling (i.e. a method
that has more stringent requirements for the film properties
(71), which we are not certain to be fulfilled for our films).
Instead, we quantified the variations in HA film thickness
upon protein incorporation by RICM. To this end, films with
837-kDaHAwere prepared on SAv-functionalized glass cover-
slips as well as on SAv-coated polystyrene colloidal probes. The
interaction between a planar HA film on the glass coverslip and
the HA film on the colloidal probe (with the colloidal probe
hovering on top of the glass surface due to weak gravitational
forces) was then monitored by RICM (Fig. 10A) in the absence
and in the presence of selected proteins. The distance between
the bead and the glass coverslip, displayed in Fig. 10B, hence
represents the interaction range across the two films.
The interaction range in the case of pureHA films was 640
28 nm. Control measurements of the thickness of planar HA
films on the glass coverslips, measured with uncoated polysty-
rene beads, and of curved HA films on the colloidal probe,
measured with an uncoated glass coverslip, gave similar thick-
nesses, each of 380 nm. The measured interaction range for
two HA films is hence about 1.7-fold larger than the thickness
of the individual HA films. To a first approximation, the inter-
action range for the encounter of two identical HA films would
be expected to be twice the thickness of individual HA films.
However, considering that the two films are likely to exhibit
some degree of interpenetration, the measured value of 1.7
appears reasonable (79).
In the presence of TSG-6, the interaction range decreased
dramatically, from 640 28 to 169 10 nm. In the presence of
II and TSG-6, the interaction range was 444  67 nm, in
agreement with our previous results (45), and for the ternary
protein mixture, this number decreased to 266  10 nm.
Clearly, the ternary mixture of TSG-6/II/PTX3 produced a
decrease in the interaction range that was less pronounced than
for TSG-6 alone yet more pronounced than for the binary mix-
ture of TSG-6/II. In contrast, when intact PTX3 in the ternary
mixture was replaced by N_PTX3_MUT, the interaction range
(456 24 nm)was comparable with the binary II/TSG-6mix-
ture. This provided a first clear indication that the dimer-form-
ing mutant of the N-terminal domain and the octameric wild
type PTX3 impact the HA film in distinct ways.
The RICM assay with two opposed HA films can also pro-
vide insight into the interaction between HA films. To this
end, we tracked the in-plane motion of HA-coated beads in
the presence of selected proteins for typically 1 min. Fig. 10C
reveals that the thermally driven random motion of the
beads is sensitive to the presence of proteins. For example,
for a pure HA film, the motion trace covered a surface area of
500 	 500 nm2, whereas it was confined to a 2500-fold
smaller area in the presence of TSG-6 alone and in the pres-
ence of the ternary mixture of II/TSG-6/PTX3. For the
binary II/TSG-6 mixture, the covered surface area was also
reduced, albeit to a lesser extent (about 25-fold). Interest-
ingly, N_PTX3_MUT did not show the same response as the
intact PTX3 protein when at a monomer concentration
equivalent to that of PTX3 octamer. Instead, the motion of
the colloidal probe was comparable with that of the binary
II/TSG-6 mixture, indicating that oligomers larger than
dimers are required for the reduction of mobility.
For quantitative comparison, we also computed the MSD
(Fig. 10, D and E) and analyzed the dependence of the MSD on
lag time. For pure HA films, we found the MSD to depend
linearly on lag time (Fig. 10D). A linear response is expected for
free diffusive motion, indicating that the lateral motion of the
HA-coated colloidal probe is not spatially constrained by the
HA-coated glass coverslip, as expected for two mutually repel-
ling films.
In stark contrast, the MSD was virtually constant for lag
times above  0.125 s in the presence of either TSG-6 alone or
the ternary TSG-6/II/PTX3mixture (i.e. the lateral motion of
FIGURE 9. Effect of PTX3 on HA film morphology. A, binding assays by
QCM-D.f andD at three selected overtones (n 5, 7, and 9) are shown. HA
films were first exposed to the protein mixtures 1.0 M II, 0.3 M TSG-6; 0.3
M PTX3, 1.0 M II, 0.3 M TSG-6; or 0.3 M N_PTX3_MUT, 1.0 M II, 0.3 M
TSG-6, with all proteins premixed (in the indicated order) shortly before the
addition to the HA films. After removal of excess protein from bulk solution,
the incorporationof PTX3 into theHAmatriceswas confirmedby theaddition
of 0.1Manti-PTX3 (MNB4). Filmsexposed to thebinary II/TSG-6mixturedid
not show any significant response to anti-PTX3. A decrease inf (blue curves)
accompanied by an increase in D (orange curves) for both ternary mixtures
evidences anti-PTX3 binding, confirming that both PTX3 and N_PTX3_MUT
can be incorporated into HA films. B, parametric plots reveal morphological
differences. Plots of D versus f are shown, for the incubation of HA films
withbinary and ternaryproteinmixtures.Datawere taken fromA, andDand
f were offset to zero shortly before the start of protein incubation. This
parametric plot provides a qualitative fingerprint of how the mechanical
properties of theHAmatrix evolve uponprotein incorporation. For thebinary
mixture and the ternary mixture containing N_PTX3_MUT, all overtones pro-
duce a roughly linear response. The slope is comparable between overtones
and also between the two protein mixtures. The latter indicates that
N_PTX3_MUT, although incorporated into the film, does not affect the film
morphology drastically as compared with the binary protein mixture. The
response for the ternary proteinmixture containingwild typePTX3 is distinct,
with a large spread between the three overtones and non-linear shapes for
n  7 and 9. This indicates that incorporation of PTX3 does affect the film
morphology appreciably.
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the beads was spatially confined to a surface area of about 70	
70 nm2). Moreover, gentle agitation of the fluid phase with a
pipette did not displace the bead (not shown). Such a response
would only be expected if the interaction between the two HA
films is attractive, and we propose that it arises from the pro-
tein-mediated cross-linking of HA. The strong effect of TSG-6,
which we had previously established to be a potent cross-linker
of HA (40), supports this hypothesis. Our data, therefore, pro-
vide indirect evidence that a ternary proteinmixture containing
PTX3 can also cross-link HA. It is interesting that although
films containing PTX3 and those containing only TSG-6 are
both stably cross-linked, they are condensed to very different
degrees (Fig. 10B). The plateau in the MSD, observed in both
scenarios (Fig. 10D), indicates that the ensemble of the protein-
mediated interactions between (and within) the two opposing
HA films is sufficiently strong to promote the formation of a
hydrogel (i.e. an HA matrix where the intermolecular interac-
tions are sufficiently strong to prevent flow).
Over the experimentally accessible range of lag times, the
MSD for the binary mixture of II and TSG-6 increased con-
FIGURE 10. Effect of proteins on HA film thickness and cross-linking. A, sketch of the experimental setup. HA films (837 kDa) were formed separately on a
planar surface and on colloidal probes, and the probeswere then added to the planar surface. The probe-surface distance (interaction range) and the in-plane
thermalmotion of the probeweremeasured by RICM, for pure HA films and in the presence of proteinmixtures. B, interaction range. Proteins were incubated
for 2 h at the indicated concentrations. Proteins were added to the HA film in sequential order: first II, either alone or in a mixture with a PTX3 construct
(octamer-formingwild type (PTX3) or dimer-formingmutant (N_PTX3_MUT); premixed for 1min) and thereafter TSG-6. Error bars, S.E. of 10measurementswith
different colloidal probes on the same sample; data are representative of at least two sets of experiments on different samples. C, representative traces of the
thermally driven random in-planemovement of a bead’s center over a period of 62.5 s for pureHA films on the planar surface and on the colloidal probe, alone
and in the presence of proteinmixtures. The scales in the x and y direction span a range of 800 nm.D, lateral MSD as a function of lag time  extracted from the
curves shown inC. Error bars correspond to statistical uncertainties for a givenmeasurement. E, MSD for  0.625 s. Error bars, S.E. of threemeasurementswith
different colloidal probes on the same sample.
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tinuously albeit sublinearly with lag time. This indicates that
the beads’ diffusivemotion is not entirely free and is affected by
attractive interactions between the HA films. The elevated
magnitude of the MSD (as compared with TSG-6 alone and
with the ternary TSG-6/II/PTX3 mixture; Fig. 10E) and the
lack of a plateau in the MSD (Fig. 10D) indicate that the attrac-
tive interaction must be relatively weak in this case. The lateral
distances explored by the bead over an observation time of 1
min were below 100 nm (Fig. 10C). This distance is more than
an order of magnitude shorter than the contour length of the
HAmolecules. It would hence be possible that, even in this case,
the confinement of the beads’ motion is due to formation of a
hydrogel, with the displacement of the bead being constrained
by tethering (i.e. cross-linking) to a few HA molecules in the
planar HA film. However, because no clear plateau in theMSD
could be observed, the response would also be consistent with
other subdiffusive motions that do not require a stable contact
between the two HA films (i.e. where the bead could explore
longer distances when given more time). Our data, therefore,
do not provide conclusive evidence for the formation of a
hydrogel by binary TSG-6/II mixtures.
Remarkably, the MSD trace for II/TSG-6/N_PTX3_MUT
was comparablewith that of the binary II/TSG-6mixture (Fig.
10, D and E), indicating that PTX3 dimers, although present in
the HA films (Fig. 9A), do not promote cross-linking. This con-
firms that strong PTX3-mediated cross-linking requires PTX3
oligomers larger than dimers, in good agreement with ex vivo
data, where it was shown that tetrameric PTX3 is the minimal
oligomeric size required for the stabilization of the COCmatrix
(30).
DISCUSSION
We have investigated the interactions between well defined
HA films and an ensemble of three proteins that are essential
for the integrity of the COC matrix: II, PTX3, and TSG-6. By
varying the sequence of protein addition to HA and by using a
range of surface-sensitive techniques, we provide new insights
into how these proteins integrate their actions inmatrix assem-
bly. We have shown that TSG-6 alone cannot mediate PTX3
incorporation into HA films; nor does PTX3 bind to HA
films that contain the products of the ternary interaction
between II, TSG-6, and HA, among which are the covalent
HCHA and HCTSG-6 complexes. Our data indicate that
prior encounter between II, alone or jointly with TSG-6,
and PTX3 leads to successful PTX3 incorporation into HA
matrices and demonstrate that native octameric PTX3 (but
not dimeric N_PTX3_MUT) in cooperation with TSG-6 and
II can create a cross-linked HA matrix.
TSG-6-mediated Binding of PTX3 to HA—Salustri et al. (12)
hypothesized that TSG-6 mediates the incorporation of PTX3
into HA matrices. More recently, surface plasmon resonance
assays have demonstrated that the binding of TSG-6 to PTX3 is
mediated by its Linkmodule and that the binding sites for PTX3
and HA are different (60). Our data on incorporation of PTX3
into HA films via Link_TSG6 are consistent with these findings
(Figs. 2A and 3A; illustrated in Fig. 11A).
However, although Leali et al. (60) reported similar affinities
of Link_TSG6 and rhTSG-6 for PTX3 (0.3 and 0.6 M, respec-
tively) and although we confirmed that both TSG-6 constructs
can bind PTX3 rather tightly (Fig. 1E), we could not find any
evidence for the incorporation of PTX3 into HA films via full-
length TSG-6 (Figs. 2B and 3B). Instead, PTX3 appeared to
inhibit the binding of TSG-6 toHA at the concentrations tested
here (Fig. 3B). What is the reason for this discrepancy? Our
previous work provided evidence that HA induces oligomeri-
zation of rhTSG-6 but not Link_TSG6, and we proposed that
the CUB_C domains of rhTSG-6 associate during oligomeriza-
tion (40). Although the CUB_C domain does not seem to be
directly involved in the interactionbetweenTSG-6andPTX3(60),
it is possible that HA-induced oligomerization of TSG-6 creates
steric constraints that impair PTX3 binding. According to this
model, the binding of PTX3 to full-length TSG-6 would probably
compete directly with TSG-6 oligomerization. We also proposed
that oligomerization is responsible for the enhanced binding of
rhTSG-6 to HA, as compared with Link_TSG6 (40). Thus, PTX3
could indirectly weaken the interaction between TSG-6 and HA.
The data presented in Fig. 3B would be consistent with such a
scenario, illustrated in Fig. 11B.
We stress in particular that the Link_TSG6 concentrations
required to promote efficient incorporation of PTX3 into HA
films exceeded those experimentally accessible for our in vitro
assays with rhTSG-6. They also far exceeded the maximum
reported in vivo concentrations of TSG-6 (80). Therefore, we
conclude that rhTSG-6 alone is unlikely to serve as an efficient
linker for the binding of PTX3 to HA under physiologically
relevant conditions.
TheDisplay of PTX3 Binding Sites in HAMatrices Appears to
Be Tightly Regulated—We also demonstrated that the incuba-
tion ofHA filmswith a binarymixture of II andTSG-6 leads to
the formation of covalent HAHC complexes and to the stable,
but non-covalent, incorporation of several othermolecules and
molecular complexes into the matrix; these include (presum-
ably HC-bound) TSG-6 and covalent HCTSG-6 complexes
(40). Considering that PTX3 is known to engage in rather
strong binary interactions with TSG-6 as well as with HCs (12,
30, 60), it is quite remarkable that such amatrix is inert to PTX3
binding (Fig. 4). Scarchilli et al. (48) suggested that TSG-6
might favor the interaction of PTX3 with HCs in HCTSG-6
complexes. We indeed found HCTSG-6 being incorporated
FIGURE 11. Interaction of PTX3with TSG-6 and HA. Sketches illustrate pro-
posed mechanisms for Link_TSG6 (A) and rhTSG-6 (B).
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intoHA films (Fig. 8B), but apparently the intermolecular inter-
actions and the local arrangement of the molecules and their
complexes in the matrix are organized in such a way that all
PTX3 binding sites are unavailable.
PTX3was incorporated intoHA films only if it was premixed
with TSG-6 and II prior to the addition to HA (Fig. 5) or if
PTX3 and II were premixed and then added to a TSG-6-con-
taining HA matrix (Fig. 6A). Clearly, protein encounters, and
perhaps the encounter of PTX3 with II in particular, play a
critical role in PTX3 incorporation. Moreover, our observation
that the TSG-6 displacement rate in sequential incubation
assays did not depend on PTX3 (Fig. 6) suggests that the initial
interaction between II and TSG-6 is not influenced by PTX3.
The presence of PTX3 did not have a detectable impact on
the qualitative composition of species detected inHA films (Fig.
8, B and C). This result is consistent with in vivo studies where
HC transfer was found to be unaffected in Ptx3/ mice (12).
The comparison of the putative HC transfer kinetics in the
sequential incubation assays (Fig. 6) and in the solution-phase
transfer assays (Fig. 7) indicated that TSG-6 is not recycled as
an HC transfer enzyme in the presence of PTX3. A plausible
explanation for the inhibition of the enzymatic function of
TSG-6 could be that TSG-6 is not released from the matrix
upon transfer of HCs but remains in a PTX3-bound state.More
specifically, we propose that the formation of HCTSG-6 com-
plexes and subsequent transfer of HCs to HA takes place in the
context of a complex of PTX3 and II with TSG-6. The reorga-
nization of this complex upon transfer of HCs from the C4S
chain of II to TSG-6 and subsequently to HA leads to the
integration of PTX3 into the HA matrix.
Although the specific interactions throughwhich PTX3 inte-
grates into the HA matrix remain elusive, it is clear from our
data that the sequence of encounters between proteins and HA
is the determinant for the correct assembly of a matrix that
contains PTX3, II, TSG-6, andHA.A remote analogy between
the formation of HA-based extracellular matrices and intracel-
lular signaling pathways can perhaps be drawn; both processes
exhibit spatio-temporal regulation and involve a hierarchy of
interactions (81). We have already proposed the concept of a
hierarchy of interactions for the assembly ofHAmatrices in our
previous work (45) and hypothesized that HCHA complexes
act as central players in matrix assembly. Here, it appears that
PTX3 has an elevated status in the sense that its incorporation
into the matrix is only realized under very specific conditions.
Structural Role of PTX3 in the Assembly of COCMatrix—We
previously provided evidence that TSG-6 alone can cross-link,
and hence stabilize, HAmatrices (40).Why then are the expres-
sion of PTX3 and the presence of II essential for the assembly
of a functional COCmatrix? Here, we demonstrate that differ-
ent combinations of proteins result in HA films with distinct
morphologies (Fig. 10). This findingmay have important impli-
cations for our understanding of the formation and molecular
organization of the COC matrix.
HA films with incorporated PTX3 became less collapsed/
condensed than HA films containing just TSG-6 (Fig. 10B).
Upon incubation with the II/TSG-6/PTX3 mixture, the HA
film thickness decreased to 260 nm,whereasTSG-6 alone led to
a thickness of 170 nm. Considering the amount of HA and pro-
teins in the films, estimated to be 450 ng/cm2 (Fig. 5A) and 600
ng/cm2 (Fig. 2B), we can calculate a water content of 98.3% and
96.5%, respectively. Clearly, both films remain highly hydrated
and hence permeable even to large proteins (Fig. 4B).
Direct measurements of the interaction forces between an
HA-coated bead and an HA-coated planar film (e.g. by atomic
force microscopy or optical tweezers) should in the future pro-
vide direct and quantitative information about the cross-link-
ing strength. The presence of weak cross-links that are revers-
ible on the time scale of interest is likely to have a major
relevance to the process of COC expansion; opening of tran-
sient cross-links can support integration of newly synthesized
HA chains into the matrix, thereby facilitating matrix growth.
Given the large size of individual HA chains, a rather low con-
centration of cross-linkers would be required to stabilize the
assembly.
To summarize, we propose thatweak, transient cross-linking
by products of the quaternary HA/II/TSG-6/PTX3 interac-
tions can simultaneously support two processes, matrix stabili-
zation andmatrix expansion. Furthermore, orchestration of the
encounter between the different protein species in time and
space may lead to spatio-temporal modulation of HA matrix
morphology. These processes may be of primary relevance not
only in formation of the COC matrix but also in inflammatory
processes that are accompanied by the coordinated expression
of TSG-6 and PTX3 and/or encounter with II (82).
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